Cargando…

Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?

Both schizophrenia and antipsychotic treatment are known to modulate brain morphology. However, it is difficult to establish whether observed structural brain abnormalities are due to disease or the effects of treatment. The aim of this study was to investigate the effects of illness and antipsychot...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Ying, Kong, Li, Wang, Jijun, Li, Chunbo, Tan, Ling, Su, Hui, Xu, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720276/
https://www.ncbi.nlm.nih.gov/pubmed/26789520
http://dx.doi.org/10.1371/journal.pone.0147204
_version_ 1782411063681089536
author Yue, Ying
Kong, Li
Wang, Jijun
Li, Chunbo
Tan, Ling
Su, Hui
Xu, Yifeng
author_facet Yue, Ying
Kong, Li
Wang, Jijun
Li, Chunbo
Tan, Ling
Su, Hui
Xu, Yifeng
author_sort Yue, Ying
collection PubMed
description Both schizophrenia and antipsychotic treatment are known to modulate brain morphology. However, it is difficult to establish whether observed structural brain abnormalities are due to disease or the effects of treatment. The aim of this study was to investigate the effects of illness and antipsychotic treatment on brain structures in antipsychotic-naïve first-episode schizophrenia based on a longitudinal short-term design. Twenty antipsychotic-naïve subjects with first-episode schizophrenia and twenty-four age- and sex-matched healthy controls underwent 3T MRI scans. Voxel-based morphometry (VBM) was used to examine the brain structural abnormality in patients compared to healthy controls. Nine patients were included in the follow-up examination after 8 weeks of treatment. Tensor-based morphometry (TBM) was used to identify longitudinal brain structural changes. We observed significantly reduced grey matter volume in the right superior temporal gyrus in antipsychotic-naïve patients with schizophrenia compared with healthy controls. After 8 weeks of treatment, patients showed significantly increased grey matter volume primarily in the bilateral prefrontal cortex, insula, right thalamus, left superior occipital cortex and the bilateral cerebellum. In addition, a greater enlargement of the prefrontal cortex is associated with the improvement in negative symptoms, and a more enlarged thalamus is associated with greater improvement in positive symptoms. Our results suggest the following: (1) the abnormality in the right superior temporal gyrus is present in the early stages of schizophrenia, possibly representing the core region related to schizophrenia; and (2) atypical antipsychotics could modulate brain morphology involving the thalamus, cortical grey matter and cerebellum. In addition, examination of the prefrontal cortex and thalamus might facilitate an efficient response to atypical antipsychotics in terms of symptom improvement.
format Online
Article
Text
id pubmed-4720276
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47202762016-01-30 Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment? Yue, Ying Kong, Li Wang, Jijun Li, Chunbo Tan, Ling Su, Hui Xu, Yifeng PLoS One Research Article Both schizophrenia and antipsychotic treatment are known to modulate brain morphology. However, it is difficult to establish whether observed structural brain abnormalities are due to disease or the effects of treatment. The aim of this study was to investigate the effects of illness and antipsychotic treatment on brain structures in antipsychotic-naïve first-episode schizophrenia based on a longitudinal short-term design. Twenty antipsychotic-naïve subjects with first-episode schizophrenia and twenty-four age- and sex-matched healthy controls underwent 3T MRI scans. Voxel-based morphometry (VBM) was used to examine the brain structural abnormality in patients compared to healthy controls. Nine patients were included in the follow-up examination after 8 weeks of treatment. Tensor-based morphometry (TBM) was used to identify longitudinal brain structural changes. We observed significantly reduced grey matter volume in the right superior temporal gyrus in antipsychotic-naïve patients with schizophrenia compared with healthy controls. After 8 weeks of treatment, patients showed significantly increased grey matter volume primarily in the bilateral prefrontal cortex, insula, right thalamus, left superior occipital cortex and the bilateral cerebellum. In addition, a greater enlargement of the prefrontal cortex is associated with the improvement in negative symptoms, and a more enlarged thalamus is associated with greater improvement in positive symptoms. Our results suggest the following: (1) the abnormality in the right superior temporal gyrus is present in the early stages of schizophrenia, possibly representing the core region related to schizophrenia; and (2) atypical antipsychotics could modulate brain morphology involving the thalamus, cortical grey matter and cerebellum. In addition, examination of the prefrontal cortex and thalamus might facilitate an efficient response to atypical antipsychotics in terms of symptom improvement. Public Library of Science 2016-01-20 /pmc/articles/PMC4720276/ /pubmed/26789520 http://dx.doi.org/10.1371/journal.pone.0147204 Text en © 2016 Yue et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Yue, Ying
Kong, Li
Wang, Jijun
Li, Chunbo
Tan, Ling
Su, Hui
Xu, Yifeng
Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
title Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
title_full Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
title_fullStr Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
title_full_unstemmed Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
title_short Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
title_sort regional abnormality of grey matter in schizophrenia: effect from the illness or treatment?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720276/
https://www.ncbi.nlm.nih.gov/pubmed/26789520
http://dx.doi.org/10.1371/journal.pone.0147204
work_keys_str_mv AT yueying regionalabnormalityofgreymatterinschizophreniaeffectfromtheillnessortreatment
AT kongli regionalabnormalityofgreymatterinschizophreniaeffectfromtheillnessortreatment
AT wangjijun regionalabnormalityofgreymatterinschizophreniaeffectfromtheillnessortreatment
AT lichunbo regionalabnormalityofgreymatterinschizophreniaeffectfromtheillnessortreatment
AT tanling regionalabnormalityofgreymatterinschizophreniaeffectfromtheillnessortreatment
AT suhui regionalabnormalityofgreymatterinschizophreniaeffectfromtheillnessortreatment
AT xuyifeng regionalabnormalityofgreymatterinschizophreniaeffectfromtheillnessortreatment